Asiaticoside and polylysine-releasing collagen complex for effectively reducing initial inflammatory response using inflamed induced in vitro model

Mater Sci Eng C Mater Biol Appl. 2021 Feb:121:111837. doi: 10.1016/j.msec.2020.111837. Epub 2021 Jan 8.

Abstract

Inflammation is a significant clinical problem that can arise from full-thickness wounds or burn injuries or microbial disease. Although topical wound healing substances could promote rapid wound healing by preventing or reducing the consequences of inflammation, there still remains a need for the development of novel substances that can effectively reduce infection and inflammation in initial wound healing phase. In this study, collagen was combined with asiaticoside (AS) and ε-poly-l-lysine (εPLL). This complex was then applied to in vitro models of infection and inflammation. Collagen-AS coatings inhibited the initial inflammatory response to LPS through a sustained release of AS, and a bilayer coating-εPLL showed a notable antimicrobial effect using microbial infection test. In this study, we determined whether asiaticoside and εPLL have anti-inflammatory and antibacterial effects through different mechanisms. Collectively, the collagen-AS/εPLL complex indicated great therapeutic potentials for accelerate wound healing and the complex may be considered as a artificial scaffold substitute product to full-thickness wound healing.

Keywords: Asiaticoside; Collagen; Inflammation; Wound infection; ε-Poly-l-lysine.

MeSH terms

  • Collagen
  • Polylysine* / pharmacology
  • Triterpenes*
  • Wound Healing

Substances

  • Triterpenes
  • Polylysine
  • Collagen
  • asiaticoside